Clinical Trials Logo

Clinical Trial Summary

MYDA-MI study is a randomized, placebo controlled, double blind study performed in San Filippo Neri Hospital, Roma, Italy. The planned study duration is 18 months. The objectives are to assess the effects of pre-treatment with probiotic Ecoviesel on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 250 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive pre-treatment with Ecoviesel sachets (each sachet contains 200 billions bacteria) or Placebo. The pre-treatment dosage will be 4 sachets of probiotic Ecoviesel or placebo for at least 2 weeks before the planned procedure. In patients undergoing angioplasty the same treatment will be continued for 4 weeks after PCI with secondary outcome measures performed at the end of this second stage.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02908776
Study type Interventional
Source San Filippo Neri General Hospital
Contact Christian Pristipino, MD
Phone +39060633062504
Email pristipino.c@gmail.com
Status Recruiting
Phase N/A
Start date September 2016
Completion date January 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01397994 - Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina. Phase 4
Active, not recruiting NCT00350922 - A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina Phase 1
Completed NCT02078921 - The Effects of Inorganic Nitrate on Cardiac Muscle in Angina Phase 2
Completed NCT02591758 - Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Active, not recruiting NCT06249581 - Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions Early Phase 1
Enrolling by invitation NCT03063697 - Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure N/A
Completed NCT01239511 - Phase IIb Study of STA-2 in Patients With Chronic Stable Angina Phase 2
Completed NCT02722213 - Mindfulness & Stress Management Study for Cardiac Patients N/A
Completed NCT01484912 - Phase II Study of STA-2 in Patients With Chronic Stable Angina Phase 2
Recruiting NCT03507361 - Myocardial Damage and Music Study N/A
Recruiting NCT03834155 - Enhancing Cardiac Rehabilitation Through Behavioral Nudges N/A
Active, not recruiting NCT02710435 - REDUCER-I: An Observational Study of the Neovasc Reducerâ„¢ System
Withdrawn NCT00518921 - Capadenoson in Angina Pectoris Phase 2
Withdrawn NCT02423265 - Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries Phase 4
Completed NCT01369472 - Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule Phase 1
Completed NCT01340248 - A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers Phase 1
Completed NCT02315001 - Liraglutide to Improve corONary Haemodynamics During Exercise streSS Phase 2
Completed NCT01760083 - A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions N/A
Unknown status NCT01558830 - Safety of Amiodarone and Ranolazine Together in Patients With Angina Phase 4